View in EDS

Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance.

Saved in:
Bibliographic Details
Title: Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance.
Authors: Schmidt C; Department of Medicine III, University Hospital, LMU Munich, Munich. Christian_Schmidt@med.uni-muenchen.de., Scheubeck G; Department of Medicine III, University Hospital, LMU Munich, Munich., Jurinovic V; Department of Medicine III, University Hospital, LMU Munich, Munich., Sökler M; Department of Medicine II, University Hospital Tuebingen, Tuebingen, Germany; Department of Oncology- and Hematology, Spital Thun, Thun., Forstpointner R; Department of Medicine III, University Hospital, LMU Munich, Munich., Buske C; Department of Medicine III, University Hospital Ulm, Ulm., Viardot A; Department of Medicine III, University Hospital Ulm, Ulm., Keller U; Department of Internal Medicine III, Klinikum Rechts der Isar der TU München, Munich, Germany; Department of Hematology and Oncology, Charité University Hospital, Campus Benjamin Franklin, Berlin., Graeven U; Department of Hematology, Oncology, Gastroenterology, Kliniken Maria Hilf GmbH, Mönchengladbach., Marks R; Department of Medicine I, University Hospital Freiburg, Freiburg., Hänel M; Department of Medicine III, Klinikum Chemnitz GmbH, Chemitz., Liersch R; GEHO, Practice for Hematology and Medical Oncology, Münster., Dürig J; Department of Hematology, University Hospital Essen, Essen., Pott C; Department of Medicine II, University Hospital Schleswig-Holstein, Kiel., Hoster E; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; Institute for Medical Information Processing, Biometry, and Epidemiology, LMU Munich., Unterhalt M; Department of Medicine III, University Hospital, LMU Munich, Munich., Hiddemann W; Department of Medicine III, University Hospital, LMU Munich, Munich.
Source: Haematologica [Haematologica] 2025 Dec 01; Vol. 110 (12), pp. 3022-3031. Date of Electronic Publication: 2025 Jun 12.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40501414
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schmidt+C%22">Schmidt C</searchLink>; Department of Medicine III, University Hospital, LMU Munich, Munich. Christian_Schmidt@med.uni-muenchen.de.<br /><searchLink fieldCode="AU" term="%22Scheubeck+G%22">Scheubeck G</searchLink>; Department of Medicine III, University Hospital, LMU Munich, Munich.<br /><searchLink fieldCode="AU" term="%22Jurinovic+V%22">Jurinovic V</searchLink>; Department of Medicine III, University Hospital, LMU Munich, Munich.<br /><searchLink fieldCode="AU" term="%22Sökler+M%22">Sökler M</searchLink>; Department of Medicine II, University Hospital Tuebingen, Tuebingen, Germany; Department of Oncology- and Hematology, Spital Thun, Thun.<br /><searchLink fieldCode="AU" term="%22Forstpointner+R%22">Forstpointner R</searchLink>; Department of Medicine III, University Hospital, LMU Munich, Munich.<br /><searchLink fieldCode="AU" term="%22Buske+C%22">Buske C</searchLink>; Department of Medicine III, University Hospital Ulm, Ulm.<br /><searchLink fieldCode="AU" term="%22Viardot+A%22">Viardot A</searchLink>; Department of Medicine III, University Hospital Ulm, Ulm.<br /><searchLink fieldCode="AU" term="%22Keller+U%22">Keller U</searchLink>; Department of Internal Medicine III, Klinikum Rechts der Isar der TU München, Munich, Germany; Department of Hematology and Oncology, Charité University Hospital, Campus Benjamin Franklin, Berlin.<br /><searchLink fieldCode="AU" term="%22Graeven+U%22">Graeven U</searchLink>; Department of Hematology, Oncology, Gastroenterology, Kliniken Maria Hilf GmbH, Mönchengladbach.<br /><searchLink fieldCode="AU" term="%22Marks+R%22">Marks R</searchLink>; Department of Medicine I, University Hospital Freiburg, Freiburg.<br /><searchLink fieldCode="AU" term="%22Hänel+M%22">Hänel M</searchLink>; Department of Medicine III, Klinikum Chemnitz GmbH, Chemitz.<br /><searchLink fieldCode="AU" term="%22Liersch+R%22">Liersch R</searchLink>; GEHO, Practice for Hematology and Medical Oncology, Münster.<br /><searchLink fieldCode="AU" term="%22Dürig+J%22">Dürig J</searchLink>; Department of Hematology, University Hospital Essen, Essen.<br /><searchLink fieldCode="AU" term="%22Pott+C%22">Pott C</searchLink>; Department of Medicine II, University Hospital Schleswig-Holstein, Kiel.<br /><searchLink fieldCode="AU" term="%22Hoster+E%22">Hoster E</searchLink>; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; Institute for Medical Information Processing, Biometry, and Epidemiology, LMU Munich.<br /><searchLink fieldCode="AU" term="%22Unterhalt+M%22">Unterhalt M</searchLink>; Department of Medicine III, University Hospital, LMU Munich, Munich.<br /><searchLink fieldCode="AU" term="%22Hiddemann+W%22">Hiddemann W</searchLink>; Department of Medicine III, University Hospital, LMU Munich, Munich.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2025 Dec 01; Vol. 110 (12), pp. 3022-3031. <i>Date of Electronic Publication: </i>2025 Jun 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40501414
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3324/haematol.2024.287162
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3022
    Titles:
      – TitleFull: Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schmidt C
      – PersonEntity:
          Name:
            NameFull: Scheubeck G
      – PersonEntity:
          Name:
            NameFull: Jurinovic V
      – PersonEntity:
          Name:
            NameFull: Sökler M
      – PersonEntity:
          Name:
            NameFull: Forstpointner R
      – PersonEntity:
          Name:
            NameFull: Buske C
      – PersonEntity:
          Name:
            NameFull: Viardot A
      – PersonEntity:
          Name:
            NameFull: Keller U
      – PersonEntity:
          Name:
            NameFull: Graeven U
      – PersonEntity:
          Name:
            NameFull: Marks R
      – PersonEntity:
          Name:
            NameFull: Hänel M
      – PersonEntity:
          Name:
            NameFull: Liersch R
      – PersonEntity:
          Name:
            NameFull: Dürig J
      – PersonEntity:
          Name:
            NameFull: Pott C
      – PersonEntity:
          Name:
            NameFull: Hoster E
      – PersonEntity:
          Name:
            NameFull: Unterhalt M
      – PersonEntity:
          Name:
            NameFull: Hiddemann W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1592-8721
          Numbering:
            – Type: volume
              Value: 110
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Haematologica
              Type: main
ResultId 1